Harrow, Inc. Shareholders' Equity
Harrow, Inc. (HROW) had Shareholders' Equity of $15.20 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-10
- 2026-06-30: Stockholders' Equity Attributable to Parent $15.20M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $28.71M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $52.45M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $47.02M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $15.20M 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $28.71M 10-Q · filed 2026-05-11 | |
| 2025-12-31 | $52.45M 10-Q · filed 2026-08-10 | |
| 2025-09-30 | $47.02M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $49.65M 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $56.45M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $69.65M 10-K · filed 2026-03-02 | |
| 2024-09-30 | $57.98M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $58.53M 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $60.56M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $70.77M 10-K · filed 2025-03-27 | |
| 2023-09-30 | $75.76M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $22.41M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $21.88M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $27.59M 10-K · filed 2024-03-19 | |
| 2022-09-30 | $1.22M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $5.75M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $10.09M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $11.29M 10-K · filed 2023-03-23 | |
| 2021-09-30 | $16.59M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $23.20M 10-Q · filed 2021-08-10 | |
| 2021-03-31 | $28.23M 10-Q · filed 2021-05-11 | |
| 2020-12-31 | $27.18M 10-K · filed 2022-03-10 | |
| 2020-09-30 | $25.27M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $15.73M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $15.34M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $27.71M 10-K · filed 2021-03-08 | |
| 2019-09-30 | $23.95M 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $35.06M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $37.06M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $24.75M 10-K · filed 2020-03-13 | |
| 2018-09-30 | $4.45M 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $3.72M 10-Q · filed 2018-08-06 | |
| 2018-03-31 | $83.00K 10-Q · filed 2019-05-09 | |
| 2017-12-31 | $2.62M 10-Q · filed 2019-05-09 | |
| 2017-09-30 | $3.75M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $7.65M 10-Q · filed 2017-08-10 | |
| 2017-03-31 | $5.32M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $6.43M 10-K · filed 2019-03-12 | |
| 2016-09-30 | $2.83M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $5.61M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $8.78M 10-Q · filed 2016-05-12 | |
| 2015-12-31 | -$1.39M 10-K · filed 2018-03-08 | |
| 2015-09-30 | $2.24M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $5.24M 10-Q · filed 2015-08-12 | |
| 2015-03-31 | $6.21M 10-Q · filed 2015-05-13 | |
| 2014-12-31 | $8.15M 10-K · filed 2017-03-21 | $8.15M 10-K · filed 2015-03-12 |
| 2014-09-30 | $10.28M 10-Q · filed 2014-11-12 | |
| 2014-06-30 | $12.04M 10-Q · filed 2014-08-13 | |
| 2014-03-31 | $13.80M 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $15.11M 10-K · filed 2016-03-23 | $15.11M 10-K · filed 2014-03-28 |
| 2013-09-30 | $16.34M 10-Q · filed 2013-11-06 | |
| 2013-06-30 | $17.27M 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $18.40M 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $10.00M 10-K · filed 2015-03-12 | |
| 2012-09-30 | $10.79M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $7.40M 10-Q · filed 2012-08-14 | |
| 2012-03-31 | -$705.81K 10-Q · filed 2012-05-10 | |
| 2011-12-31 | -$1.70M 10-K · filed 2014-03-28 | |
| 2011-09-30 | -$1.57M 10-Q · filed 2012-02-23 | |
| 2011-06-30 | -$1.52M 10-Q · filed 2012-02-23 | |
| 2010-12-31 | -$1.04M 10-K · filed 2014-03-28 | |
| 2009-12-31 | $577.21K 10-K · filed 2014-03-28 | |
| 2008-12-31 | $4.57M 10-K · filed 2014-03-28 | |
| 2007-12-31 | $3.49M 10-K · filed 2014-03-28 | |
| 2006-12-31 | -$406.00K 10-K · filed 2014-03-28 | |
| 2005-12-31 | -$272.77K 10-K · filed 2014-03-28 | |
| 2004-12-31 | -$163.15K 10-K · filed 2014-03-28 | |
| 2003-12-31 | -$54.92K 10-K · filed 2014-03-28 | |
| 2002-12-31 | -$47.73K 10-K · filed 2014-03-28 | |
| 2001-12-31 | -$19.51K 10-K · filed 2014-03-28 | |
| 2000-12-31 | -$11.09K 10-K · filed 2014-03-28 | |
| 1999-12-31 | -$4.00K 10-K · filed 2014-03-28 | |
| 1998-12-31 | $0.00 10-K · filed 2013-03-18 | |
| 1998-06-23 | $0.00 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |